Gannet BioChem
Huntsville, Alabama, United States · Biotechnology, Manufacturing
Gannet BioChem is a leading specialty CDMO with over 30 years of expertise in developing, scaling, and manufacturing polyethylene glycol (PEG) reagents—essential components in advanced biopharmaceutical and therapeutic products. Operating from a 124,000 sq. ft. FDA-inspected facility in Huntsville, Alabama, the company provides end-to-end GMP production to support both clinical and commercial ther
Key facts
- Headquarters
- Huntsville, Alabama, United States
- Employees
- 53
- Industries
- Biotechnology, Manufacturing
- Status
- Private
- Website
- www.gannetbiochem.com
- Company page
Recent activity at Gannet BioChem
Leadership
- Bob Rodebaugh, Vice President of Technology
- Tony Sander, Chief Operating Officer
- Chris Edwards, Chief Financial Officer
- Nicholas Shackley, Chief Executive Officer
Verified email and direct lines for Gannet BioChem’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Companies similar to Gannet BioChem
- RCE Technologies · Biotechnology, Manufacturing
- Micropep Technologies · Biotechnology, Manufacturing
- PDV MedTech · Biotechnology, Manufacturing
- Special Optics · Biotechnology, Manufacturing
- Cornerstone Robotics · Biotechnology, Manufacturing
About Gannet BioChem: questions and answers
What does Gannet BioChem do?
Gannet BioChem is a leading specialty CDMO with over 30 years of expertise in developing, scaling, and manufacturing polyethylene glycol (PEG) reagents—essential components in advanced biopharmaceutical and therapeutic products. Operating from a 124,000 sq. ft. FDA-inspected facility in Huntsville, Alabama, the company provides end-to-end GMP production to support both clinical and commercial ther
Where is Gannet BioChem headquartered?
Gannet BioChem is headquartered in Huntsville, Alabama, United States.
How many employees does Gannet BioChem have?
Gannet BioChem has about 53 employees.
Who leads Gannet BioChem?
Bob Rodebaugh is a Vice President of Technology at Gannet BioChem.
What is the latest news on Gannet BioChem?
On Jun 30, 2026, Gannet BioChem Partners with Serina Therapeutics to Advance SER-252 for Parkinson's Disease.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy